Company Monitoring Page for Sandoz

latest headlines for company on cafepharma

EQT, Biontech investor family consider Sandoz bid
Yahoo/Reuters
Fri, 11/19/21 - 11:12 am
Tags:
EQT, BioNTech, Sandoz, generics, Novartis, M&A
Swiss socialists say government should buy Sandoz
Pharmaforum
Mon, 11/8/21 - 10:38 am
Tags:
Switzerland, Novartis, Sandoz, M&A, generics
What Novartis could buy with its windfall
EP Vantage
Fri, 11/5/21 - 09:40 am
Tags:
Novartis, M&A, Roche, Sandoz, Aurinia Pharmaceuticals, Alnylam, Exelixis, Incyte, Eisai, Genmab
Novartis looking into future of its Sandoz’ generics business
Pharmaforum
Tue, 10/26/21 - 10:30 am
Tags:
Novartis, generics, Sandoz
Three generic firms shell out $447M more to settle federal price fixing allegations
Endpoints
Mon, 10/4/21 - 10:59 am
Tags:
generics, legal, price fixing, Taro Pharmaceuticals, Sandoz, Novartis, Apotex
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028
Fierce Pharma
Tue, 09/21/21 - 10:54 am
Tags:
Amgen, Otezla, psoriasis, generics, Sandoz, market exclusivity, patents
Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biopharma Reporter
Wed, 09/8/21 - 11:15 am
Tags:
Sandoz, Novartis, biosimilars, China, BAT1706, Bio-Thera Solutions
Novartis' Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
Fierce Pharma
Tue, 05/18/21 - 11:01 am
Tags:
Novartis, Sandoz, generics, Europe, drug manufacturing
Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein
Fierce Pharma
Mon, 05/17/21 - 10:59 pm
Tags:
Novartis, Sandoz, generics, Supreme Court, Amgen, Embrel, biosimilar
Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity
Endpoints
Tue, 03/9/21 - 10:49 am
Tags:
Novartis, generics, Sandoz, FDA, Aubagio, multiple sclerosis, MS
GlaxoSmithKline to shut down antibiotics production, cut 300 jobs in wake of Novartis buyout
Fierce Pharma
Fri, 02/12/21 - 11:09 am
Tags:
GSK, Novartis, Sandoz, layoffs, antibiotics, drug manufacturing
Novartis' Sandoz doubles down on antibiotics with $500M deal for GSK brands
Fierce Pharma
Thu, 02/11/21 - 10:26 pm
Tags:
Novartis, Sandoz, generics, antibiotics
Sandoz working to overcome barriers to greater biosimilars uptake in US
Biopharma Reporter
Mon, 09/21/20 - 10:55 am
Tags:
Sandoz, biosimilars, Novartis
Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing
BioPharma Dive
Mon, 07/27/20 - 11:05 pm
Tags:
Novartis, Sandoz, Europe, antibiotics, drug manufacturing
Novartis to provide 'no profit' COVID-19 drugs to low income countries
Reuters
Thu, 07/16/20 - 11:00 am
Tags:
Novartis, Sandoz, non-profits, developing countries, generics
Teva bails on price-fixing settlement in gamble on its role fighting COVID-19: report
Fierce Pharma
Mon, 05/18/20 - 10:56 pm
Tags:
Teva Pharmaceutical, price fixing, generics, COVID-19, Sandoz, JNJ, Novartis, Taro Pharmaceuticals
Novartis cancels $1B sale of generics after antitrust concerns forced delays
Endpoints
Thu, 04/2/20 - 10:49 am
Tags:
Novartis, generics, Sandoz, antitrust
Sandoz Pays $195 Million to Settle Criminal Antitrust Charges in Sweeping Federal Probe
BioSpace
Tue, 03/3/20 - 10:55 am
Tags:
Sandoz, generics, Novartis, antitrust
Sandoz pledges 'stable' pricing for generics, antibiotics amid COVID-19 supply chain worries
Fierce Pharma
Thu, 02/27/20 - 10:39 am
Tags:
Sandoz, generics, antibiotics, COVID-19, coronaviruses
Former Novartis exec pleads guilty to generic price fixing
Endpoints
Tue, 02/18/20 - 10:25 am
Tags:
Novartis, Sandoz, price fixing, generics, DOJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.